Global Biopharmaceuticals Market Size, Manufacturers, Opportunities and Forecast to 2030

Global Biopharmaceuticals Market Size, Manufacturers, Opportunities and Forecast to 2030


Summary

A biopharmaceutical, also known as a biologic (al) medical product, biological, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semi synthesized from biological sources. Different from totally synthesized pharmaceuticals, they include vaccines, blood, blood components, allergenic, somatic cells, gene therapies, tissues, recombinant therapeutic protein, and living cells used in cell therapy. Biologics can be composed of sugars, proteins, or nucleic acids or complex combinations of these substances, or may be living cells or tissues. They (or their precursors or components) are isolated from living sources—human, animal, plant, fungal, or microbial.
According to APO Research, The global Biopharmaceuticals market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North American market for Biopharmaceuticals is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Biopharmaceuticals is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Biopharmaceuticals is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global companies of Biopharmaceuticals include Roche, Amgen, AbbVie, Sanofi-Aventis, Johnson & Johnson, Pfizer, Novo Nordisk, Eli Lilly and Novartis, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Biopharmaceuticals, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biopharmaceuticals.
The Biopharmaceuticals market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Biopharmaceuticals market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, gross margin by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

Roche
Amgen
AbbVie
Sanofi-Aventis
Johnson & Johnson
Pfizer
Novo Nordisk
Eli Lilly
Novartis
Merck
Sun
3sbio
Changchun High Tech
CP Guojian
Biotech
Gelgen
Innovent
Dong Bao
Ganlee
United Laboratories
SANDOZ (NOVARTIS)
Teva Pharmaceutical
Hospira (Pfizer)
MYLAN
Sun pharma
Biopharmaceuticals segment by Type

Monoclonal Antibodies
Interferon
Colony-Stimulating Factor
Erythropoietin
Insulin
Vaccines
Growth Hormones
Others
Biopharmaceuticals segment by Application

Tumor
Diabetes
Cardiovascular
Hemophilia
Others
Biopharmaceuticals Segment by Region

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biopharmaceuticals market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Biopharmaceuticals and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biopharmaceuticals.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2019-2024, 2025-2030). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Biopharmaceuticals companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report


1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.3 Global Biopharmaceuticals Market Size Overview by Region 2019 VS 2023 VS 2030
1.4 Global Biopharmaceuticals Market Size by Region (2019-2030)
1.4.1 Global Biopharmaceuticals Market Size by Region (2019-2024)
1.4.2 Global Biopharmaceuticals Market Size by Region (2025-2030)
1.5 Key Regions Biopharmaceuticals Market Size (2019-2030)
1.5.1 North America Biopharmaceuticals Market Size Growth Rate (2019-2030)
1.5.2 Europe Biopharmaceuticals Market Size Growth Rate (2019-2030)
1.5.3 Asia-Pacific Biopharmaceuticals Market Size Growth Rate (2019-2030)
1.5.4 Latin America Biopharmaceuticals Market Size Growth Rate (2019-2030)
1.5.5 Middle East & Africa Biopharmaceuticals Market Size Growth Rate (2019-2030)
2 Biopharmaceuticals Market by Type
2.1 Type Introduction
2.1.1 Monoclonal Antibodies
2.1.2 Interferon
2.1.3 Colony-Stimulating Factor
2.1.4 Erythropoietin
2.1.5 Insulin
2.1.6 Vaccines
2.1.7 Growth Hormones
2.1.8 Others
2.2 Global Biopharmaceuticals Market Size by Type
2.2.1 Global Biopharmaceuticals Market Size Overview by Type (2019-2030)
2.2.2 Global Biopharmaceuticals Historic Market Size Review by Type (2019-2024)
2.2.3 Global Biopharmaceuticals Market Size Forecasted by Type (2025-2030)
2.3 Global Biopharmaceuticals Market Size by Regions
2.3.1 North America Biopharmaceuticals Market Size Breakdown by Type (2019-2024)
2.3.2 Europe Biopharmaceuticals Market Size Breakdown by Type (2019-2024)
2.3.3 Asia-Pacific Biopharmaceuticals Market Size Breakdown by Type (2019-2024)
2.3.4 Latin America Biopharmaceuticals Market Size Breakdown by Type (2019-2024)
2.3.5 Middle East and Africa Biopharmaceuticals Market Size Breakdown by Type (2019-2024)
3 Biopharmaceuticals Market by Application
3.1 Type Introduction
3.1.1 Tumor
3.1.2 Diabetes
3.1.3 Cardiovascular
3.1.4 Hemophilia
3.1.5 Others
3.2 Global Biopharmaceuticals Market Size by Application
3.2.1 Global Biopharmaceuticals Market Size Overview by Application (2019-2030)
3.2.2 Global Biopharmaceuticals Historic Market Size Review by Application (2019-2024)
3.2.3 Global Biopharmaceuticals Market Size Forecasted by Application (2025-2030)
3.3 Global Biopharmaceuticals Market Size by Regions
3.3.1 North America Biopharmaceuticals Market Size Breakdown by Application (2019-2024)
3.3.2 Europe Biopharmaceuticals Market Size Breakdown by Application (2019-2024)
3.3.3 Asia-Pacific Biopharmaceuticals Market Size Breakdown by Application (2019-2024)
3.3.4 Latin America Biopharmaceuticals Market Size Breakdown by Application (2019-2024)
3.3.5 Middle East and Africa Biopharmaceuticals Market Size Breakdown by Application (2019-2024)
4 Global Market Dynamics
4.1 Biopharmaceuticals Industry Trends
4.2 Biopharmaceuticals Industry Drivers
4.3 Biopharmaceuticals Industry Opportunities and Challenges
4.4 Biopharmaceuticals Industry Restraints
5 Competitive Insights by Company
5.1 Global Top Players by Biopharmaceuticals Revenue (2019-2024)
5.2 Global Biopharmaceuticals Industry Company Ranking, 2022 VS 2023 VS 2024
5.3 Global Biopharmaceuticals Key Company Headquarters & Area Served
5.4 Global Biopharmaceuticals Company, Product Type & Application
5.5 Global Biopharmaceuticals Company Commercialization Time
5.6 Market Competitive Analysis
5.6.1 Global Biopharmaceuticals Market CR5 and HHI
5.6.2 Global Top 5 and 10 Biopharmaceuticals Players Market Share by Revenue in 2023
5.6.3 2023 Biopharmaceuticals Tier 1, Tier 2, and Tier 3
6 Company Profiles
6.1 Roche
6.1.1 Roche Comapny Information
6.1.2 Roche Business Overview
6.1.3 Roche Biopharmaceuticals Revenue, Global Share and Gross Margin (2019-2024)
6.1.4 Roche Biopharmaceuticals Product Portfolio
6.1.5 Roche Recent Developments
6.2 Amgen
6.2.1 Amgen Comapny Information
6.2.2 Amgen Business Overview
6.2.3 Amgen Biopharmaceuticals Revenue, Global Share and Gross Margin (2019-2024)
6.2.4 Amgen Biopharmaceuticals Product Portfolio
6.2.5 Amgen Recent Developments
6.3 AbbVie
6.3.1 AbbVie Comapny Information
6.3.2 AbbVie Business Overview
6.3.3 AbbVie Biopharmaceuticals Revenue, Global Share and Gross Margin (2019-2024)
6.3.4 AbbVie Biopharmaceuticals Product Portfolio
6.3.5 AbbVie Recent Developments
6.4 Sanofi-Aventis
6.4.1 Sanofi-Aventis Comapny Information
6.4.2 Sanofi-Aventis Business Overview
6.4.3 Sanofi-Aventis Biopharmaceuticals Revenue, Global Share and Gross Margin (2019-2024)
6.4.4 Sanofi-Aventis Biopharmaceuticals Product Portfolio
6.4.5 Sanofi-Aventis Recent Developments
6.5 Johnson & Johnson
6.5.1 Johnson & Johnson Comapny Information
6.5.2 Johnson & Johnson Business Overview
6.5.3 Johnson & Johnson Biopharmaceuticals Revenue, Global Share and Gross Margin (2019-2024)
6.5.4 Johnson & Johnson Biopharmaceuticals Product Portfolio
6.5.5 Johnson & Johnson Recent Developments
6.6 Pfizer
6.6.1 Pfizer Comapny Information
6.6.2 Pfizer Business Overview
6.6.3 Pfizer Biopharmaceuticals Revenue, Global Share and Gross Margin (2019-2024)
6.6.4 Pfizer Biopharmaceuticals Product Portfolio
6.6.5 Pfizer Recent Developments
6.7 Novo Nordisk
6.7.1 Novo Nordisk Comapny Information
6.7.2 Novo Nordisk Business Overview
6.7.3 Novo Nordisk Biopharmaceuticals Revenue, Global Share and Gross Margin (2019-2024)
6.7.4 Novo Nordisk Biopharmaceuticals Product Portfolio
6.7.5 Novo Nordisk Recent Developments
6.8 Eli Lilly
6.8.1 Eli Lilly Comapny Information
6.8.2 Eli Lilly Business Overview
6.8.3 Eli Lilly Biopharmaceuticals Revenue, Global Share and Gross Margin (2019-2024)
6.8.4 Eli Lilly Biopharmaceuticals Product Portfolio
6.8.5 Eli Lilly Recent Developments
6.9 Novartis
6.9.1 Novartis Comapny Information
6.9.2 Novartis Business Overview
6.9.3 Novartis Biopharmaceuticals Revenue, Global Share and Gross Margin (2019-2024)
6.9.4 Novartis Biopharmaceuticals Product Portfolio
6.9.5 Novartis Recent Developments
6.10 Merck
6.10.1 Merck Comapny Information
6.10.2 Merck Business Overview
6.10.3 Merck Biopharmaceuticals Revenue, Global Share and Gross Margin (2019-2024)
6.10.4 Merck Biopharmaceuticals Product Portfolio
6.10.5 Merck Recent Developments
6.11 Sun
6.11.1 Sun Comapny Information
6.11.2 Sun Business Overview
6.11.3 Sun Biopharmaceuticals Revenue, Global Share and Gross Margin (2019-2024)
6.11.4 Sun Biopharmaceuticals Product Portfolio
6.11.5 Sun Recent Developments
6.12 3sbio
6.12.1 3sbio Comapny Information
6.12.2 3sbio Business Overview
6.12.3 3sbio Biopharmaceuticals Revenue, Global Share and Gross Margin (2019-2024)
6.12.4 3sbio Biopharmaceuticals Product Portfolio
6.12.5 3sbio Recent Developments
6.13 Changchun High Tech
6.13.1 Changchun High Tech Comapny Information
6.13.2 Changchun High Tech Business Overview
6.13.3 Changchun High Tech Biopharmaceuticals Revenue, Global Share and Gross Margin (2019-2024)
6.13.4 Changchun High Tech Biopharmaceuticals Product Portfolio
6.13.5 Changchun High Tech Recent Developments
6.14 CP Guojian
6.14.1 CP Guojian Comapny Information
6.14.2 CP Guojian Business Overview
6.14.3 CP Guojian Biopharmaceuticals Revenue, Global Share and Gross Margin (2019-2024)
6.14.4 CP Guojian Biopharmaceuticals Product Portfolio
6.14.5 CP Guojian Recent Developments
6.15 Biotech
6.15.1 Biotech Comapny Information
6.15.2 Biotech Business Overview
6.15.3 Biotech Biopharmaceuticals Revenue, Global Share and Gross Margin (2019-2024)
6.15.4 Biotech Biopharmaceuticals Product Portfolio
6.15.5 Biotech Recent Developments
6.16 Gelgen
6.16.1 Gelgen Comapny Information
6.16.2 Gelgen Business Overview
6.16.3 Gelgen Biopharmaceuticals Revenue, Global Share and Gross Margin (2019-2024)
6.16.4 Gelgen Biopharmaceuticals Product Portfolio
6.16.5 Gelgen Recent Developments
6.17 Innovent
6.17.1 Innovent Comapny Information
6.17.2 Innovent Business Overview
6.17.3 Innovent Biopharmaceuticals Revenue, Global Share and Gross Margin (2019-2024)
6.17.4 Innovent Biopharmaceuticals Product Portfolio
6.17.5 Innovent Recent Developments
6.18 Dong Bao
6.18.1 Dong Bao Comapny Information
6.18.2 Dong Bao Business Overview
6.18.3 Dong Bao Biopharmaceuticals Revenue, Global Share and Gross Margin (2019-2024)
6.18.4 Dong Bao Biopharmaceuticals Product Portfolio
6.18.5 Dong Bao Recent Developments
6.19 Ganlee
6.19.1 Ganlee Comapny Information
6.19.2 Ganlee Business Overview
6.19.3 Ganlee Biopharmaceuticals Revenue, Global Share and Gross Margin (2019-2024)
6.19.4 Ganlee Biopharmaceuticals Product Portfolio
6.19.5 Ganlee Recent Developments
6.20 United Laboratories
6.20.1 United Laboratories Comapny Information
6.20.2 United Laboratories Business Overview
6.20.3 United Laboratories Biopharmaceuticals Revenue, Global Share and Gross Margin (2019-2024)
6.20.4 United Laboratories Biopharmaceuticals Product Portfolio
6.20.5 United Laboratories Recent Developments
6.21 SANDOZ (NOVARTIS)
6.21.1 SANDOZ (NOVARTIS) Comapny Information
6.21.2 SANDOZ (NOVARTIS) Business Overview
6.21.3 SANDOZ (NOVARTIS) Biopharmaceuticals Revenue, Global Share and Gross Margin (2019-2024)
6.21.4 SANDOZ (NOVARTIS) Biopharmaceuticals Product Portfolio
6.21.5 SANDOZ (NOVARTIS) Recent Developments
6.22 Teva Pharmaceutical
6.22.1 Teva Pharmaceutical Comapny Information
6.22.2 Teva Pharmaceutical Business Overview
6.22.3 Teva Pharmaceutical Biopharmaceuticals Revenue, Global Share and Gross Margin (2019-2024)
6.22.4 Teva Pharmaceutical Biopharmaceuticals Product Portfolio
6.22.5 Teva Pharmaceutical Recent Developments
6.23 Hospira (Pfizer)
6.23.1 Hospira (Pfizer) Comapny Information
6.23.2 Hospira (Pfizer) Business Overview
6.23.3 Hospira (Pfizer) Biopharmaceuticals Revenue, Global Share and Gross Margin (2019-2024)
6.23.4 Hospira (Pfizer) Biopharmaceuticals Product Portfolio
6.23.5 Hospira (Pfizer) Recent Developments
6.24 MYLAN
6.24.1 MYLAN Comapny Information
6.24.2 MYLAN Business Overview
6.24.3 MYLAN Biopharmaceuticals Revenue, Global Share and Gross Margin (2019-2024)
6.24.4 MYLAN Biopharmaceuticals Product Portfolio
6.24.5 MYLAN Recent Developments
6.25 Sun pharma
6.25.1 Sun pharma Comapny Information
6.25.2 Sun pharma Business Overview
6.25.3 Sun pharma Biopharmaceuticals Revenue, Global Share and Gross Margin (2019-2024)
6.25.4 Sun pharma Biopharmaceuticals Product Portfolio
6.25.5 Sun pharma Recent Developments
7 North America
7.1 North America Biopharmaceuticals Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.2 North America Biopharmaceuticals Market Size by Country (2019-2024)
7.3 North America Biopharmaceuticals Market Size Forecast by Country (2025-2030)
8 Europe
8.1 Europe Biopharmaceuticals Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.2 Europe Biopharmaceuticals Market Size by Country (2019-2024)
8.3 Europe Biopharmaceuticals Market Size Forecast by Country (2025-2030)
9 Asia-Pacific
9.1 Asia-Pacific Biopharmaceuticals Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.2 Asia-Pacific Biopharmaceuticals Market Size by Country (2019-2024)
9.3 Asia-Pacific Biopharmaceuticals Market Size Forecast by Country (2025-2030)
10 Latin America
10.1 Latin America Biopharmaceuticals Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.2 Latin America Biopharmaceuticals Market Size by Country (2019-2024)
10.3 Latin America Biopharmaceuticals Market Size Forecast by Country (2025-2030)
11 Middle East & Africa
11.1 Middle East & Africa Biopharmaceuticals Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.2 Middle East & Africa Biopharmaceuticals Market Size by Country (2019-2024)
11.3 Middle East & Africa Biopharmaceuticals Market Size Forecast by Country (2025-2030)
12 Concluding Insights
13 Appendix
13.1 Reasons for Doing This Study
13.2 Research Methodology
13.3 Research Process
13.4 Authors List of This Report
13.5 Data Source
13.5.1 Secondary Sources
13.5.2 Primary Sources

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings